Kinanah Yaseen, MD, was awarded the 2020 Vasculitis Clinical Research Consortium (VCRC)-Vasculitis Foundation (VF) Fellowship. She is currently a junior faculty member in the Department of Rheumatic and Immunologic Diseases at Cleveland Clinic. Her interests involve all forms of vasculitis, especially small vessel vasculitis including granulomatosis with polyangiitis (GPA), microscopic…...
Kathy Olevsky: Enjoying Life in Remission from MPA and Pursuing Her Passions
After Kathy Olevsky was diagnosed with ANCA-associated microscopic polyangiitis (MPA) in 2009, it took her about a year to realize that she would never be the same person she was before she became sick. But when you read her story, you’ll see that this determined 62-year-old is not only surviving,…...
Rituximab Gains Expanded Approval in Pediatrics
The Food and Drug Administration has expanded the approval of Rituxan® injection (rituximab) to include the treatment of children ≥2 years of age who have granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), in combination with glucocorticoids. Rituximab is a CD20-directed cytolytic monoclonal antibody first approved in 1997 to…...
Maitland, Florida, Internist/Anesthesiologist Ties for First Place in Vasculitis Foundation’s 2019 V-RED Award Program
Dr. Mark Anderson’s research and gut instinct ultimately prevented his wife’s vasculitis from becoming worse. (Maitland, Florida, October 2019) Mark Anderson, MD, shared first place honors in the Vasculitis Foundation’s (VF’s) 2019 Recognizing Excellence in Diagnostics (V-RED) award program. Dr. Anderson’s patient, his wife Nancy Anderson, was trying to get…...
